Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
659 participants
OBSERVATIONAL
2016-01-01
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What are the risk factors for RAP?
2. How to predict RAP?
All patients with acute pancreatitis will be given standardized treatment for the condition.
The researchers will compare the RAP group with the non-RAP group to find the risk factors for RAP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
NCT06553040
Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis
NCT06364397
Early Detection of PDAC in Patients With Chronic Pancreatitis
NCT07104864
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502
PROOF: Pancreatitis-associated Risk Of Organ Failure
NCT03075605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recurrent acute pancreatitis
No interventions assigned to this group
Non-recurrent acute pancreatitis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Systematic examination and diagnostic information were available after admission
Exclusion Criteria
* The duration of hospital stay was less than 24 hours
* Died within the first episode of AP
* A history of chronic pancreatitis or tumor
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qinghao Wang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qinghao Wang
Master of Medicine
References
Explore related publications, articles, or registry entries linked to this study.
Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, Pollard TJ, Hao S, Moody B, Gow B, Lehman LH, Celi LA, Mark RG. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023 Jan 3;10(1):1. doi: 10.1038/s41597-022-01899-x.
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20200047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.